These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 15842551
21. Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Fernández-Varón E, Bovaira MJ, Espuny A, Escudero E, Vancraeynest D, Cárceles CM. J Vet Pharmacol Ther; 2005 Aug; 28(4):343-8. PubMed ID: 16050813 [Abstract] [Full Text] [Related]
24. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. Stass H, Schühly U, Möller JG, Delesen H. Clin Pharmacokinet; 2001 Aug; 40 Suppl 1():49-55. PubMed ID: 11352442 [Abstract] [Full Text] [Related]
26. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. Cárceles CM, Escudero E, Fernández-Varón E, Marín P. Vet J; 2009 Jun; 180(3):343-7. PubMed ID: 18406644 [Abstract] [Full Text] [Related]
31. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
32. The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction. Stass H, Bührmann S, Mitchell A, Kubitza D, Möller JG, Kribben A, Wenzel RR, Schäfers RF. Br J Clin Pharmacol; 2007 Dec; 64(6):745-9. PubMed ID: 17555469 [Abstract] [Full Text] [Related]
33. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. Ullah MA, Shams-Ud-Dowla, Maruf AA, Azad MA, Shohag MH, Sultana R, Latif AH, Hasnat A. Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688 [Abstract] [Full Text] [Related]
34. Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study. de Smet J, Colpaert K, de Paepe P, van Bocxlaer J, Decruyenaere J, Boussery K. Scand J Infect Dis; 2012 Nov; 44(11):874-8. PubMed ID: 22804100 [Abstract] [Full Text] [Related]
35. Effects of urine alkalization and activated charcoal on the pharmacokinetics of orally administered carprofen in dogs. Raekallio MR, Honkavaara JM, Säkkinen MS, Peltoniemi SM. Am J Vet Res; 2007 Apr; 68(4):423-7. PubMed ID: 17397299 [Abstract] [Full Text] [Related]
38. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. Krauwinkel W, van Dijk J, Schaddelee M, Eltink C, Meijer J, Strabach G, van Marle S, Kerbusch V, van Gelderen M. Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375 [Abstract] [Full Text] [Related]